ClinicalTrials.gg
RecruitingNCT03614585Updated Oct 19, 2023

Exercise Intensity Matters in Stroke Rehabilitation

An interventional study of 12 weeks of High-intensity Interval Training and 12 weeks of Moderate-Intensity Continuous Training in Stroke, sponsored by McGill University. Recruiting at 2 sites in Canada. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-10-19.

Sponsored by McGill University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started Jan 2020; still recruiting 6 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Stroke by McGill University — 7 open to participants now, 7 under way, none of them phase 3. Stroke · McGill University.

Planned enrollment
3rd of 15
80 · median 40
Started
2020
with 2 others
No phase
15 of 16
6 open now
Registered
4th of 16
by date

Among the 16 studies in Stroke by McGill University, this one is the 3rd largest by planned enrollment of the 15 interventional ones that give a count, is one of 3 that started in 2020, is one of 15 with no phase, and was the 4th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

7 of the 16 studies in Stroke by McGill University are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 40 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Stroke by McGill University, or all of them as a file.
02

Study summary

The main objective of this multi-site project is to compare the effects of 12 weeks of HIIT vs. MICT on brain plasticity. The effects of HIIT vs. MICT on cardiovascular health, psychosocial predictors of physical activity and motor function will also be compared. HIIT and MICT will be delivered through a whole-body exercise paradigm using a recumbent stepper that requires arm and leg forces. Outcomes will be assessed at baseline (T0, 0 weeks), at the end of the intervention (T1, 12 weeks) and at 8-week follow-up (T2, 20 weeks).

Read the detailed description

Background: Stroke is a major health issue in Canada, with 405,000 Canadians currently living with stroke. Exercise is an important component of stroke rehabilitation that can result in improved function and health. Traditionally, exercise rehabilitation programs for stroke employ moderate-intensity continuous training (MICT) protocols that are typically sustained for 20-30 minutes. The continuous nature of this form of training however, even at moderate intensities, is challenging for many individuals with stroke to sustain due to neuromotor impairments and poor exercise capacity. High-intensity exercise, when delivered in short interval bursts (i.e. high-intensity interval training, HIIT), may be a feasible alternative that allows higher intensities to be achieved during exercise. This is important because intensity of training is the critical factor in promoting changes in neuroplasticity and cardiovascular health, the two most important aspects of recovery and secondary prevention after stroke. Interventions implemented earlier following stroke are generally viewed to yield greater benefits, but high intensity exercise may also promote neuroplasticity and optimize cardiovascular health in later stages of recovery. Furthermore, determining if HIIT is viewed to be motivating and enjoyable for individuals post-stroke can provide insight into the sustainability of this intervention.

Objective: To compare the effects of 12 weeks of HIIT and MICT on neuroplasticity, cardiovascular health and psychosocial predictors of physical activity in individuals with chronic stroke.

Design: Participants will be recruited from two research sites and randomly allocated into HIIT or MICT. Participants will be assessed before and after the training period, and at an 8-week follow-up.

Outcomes: 1) The investigators will assess: Neuroplasticity: by measuring markers of corticospinal excitability at rest and in response to a non-invasive brain stimulation protocol applied over the primary motor cortex (M1); 2) Cardiovascular health: by measuring cardiorespiratory fitness, resting blood pressure, arterial stiffness, and waist-hip ratio; 3) Psychosocial predictors of physical activity: by measuring exercise motivation and enjoyment.

Methods: Neuroplasticity: motor evoked potentials amplitude, intracortical facilitation and short-intracortical inhibition on the lesioned and unlesioned upper limb M1 area at rest and in response to continuous theta-burst will be measured with transcranial magnetic stimulation; Cardiovascular health: cardiorespiratory fitness will be measured with a graded exercise test, resting blood pressure with an automated blood pressure monitor and arterial stiffness using applanation tonometry. Exercise motivation and enjoyment will be assessed with the Physical Activity Enjoyment Scale and the Behavioral Regulation Exercise Questionnaire-3, respectively.

Expected results: Both HIIT and MICT will result in improvements in outcomes of neuroplasticity and cardiovascular health. However, improvements with HIIT will be greater and will last longer. Participants will rate HIIT as enjoyable as MICT, and motivation for exercise will increase similarly after both interventions.

Impact: HIIT is a promising, time-efficient, and potentially more effective alternative to traditional MICT protocols that could offer an opportunity for greater improvement in motor recovery and cardiovascular health in people living with stroke.

03

Conditions studied

  • Stroke

Keywords

  • Stroke
  • Rehabilitation
  • Neurosciences
  • Exercise
  • Neurorecovery
  • Cardiovascular health
  • High-intensity interval training
  • Moderate-intensity continuous training
04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 6-60 months following first-ever, single stroke confirmed by MRI/CT
  • Living in the community and able to independently walk at least 10 meters (assistive devices permitted, as this is representative of many people who regain some walking ability following stroke but commonly with some adaptation)
  • score >20 (individuals with this score are capable to follow exercise instructions)

Exclusion criteria

Exclusion Criteria:

  • Significant disability as determined by modified Rankin scale score \<2
  • Stroke of non-cardiogenic origin or tumor
  • Actively engaged in stroke rehabilitation services or a structured exercise program besides the one provided in the study
  • Class C or D American Heart Association Risk Criteria
  • Other neurological or musculoskeletal co-morbidities that preclude exercise participation
  • Pain which is worsened with exercise
  • Cognitive, communication, or behavioral issues that would limit safe exercise participation
  • to transcranial magnetic stimulation.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    High-intensity interval training

    Intensity will be determined using a combination of heart rate reserve (HRR, calculated as HRR= \[max HR - resting HR\] x \[% training\] + \[resting HR\]) and ratings of perceived exertion (RPE). The protocol will involve 10 60-second intervals of high intensity interspersed with 9 60-second low-intensity intervals. The initial high intensity intervals will start at 80% of the HRR (RPE=14-17) and progress by 10% every 4 weeks. Low intensity intervals will be performed at 30% of HRR (RPE=9-11). Three-minute warm-up and 2-minute cool-down periods will be performed at 30% of HRR. Total HIIT time including warm-up and cool-down is 24 minutes.

    Behavioral: 12 weeks of High-intensity Interval Training

  • Experimental
    Moderate-intensity continuous training

    Intensity will be determined using a combination of heart rate reserve (HRR, calculated as HRR= \[max HR - resting HR\] x \[% training\] + \[resting HR\]) and ratings of perceived exertion (RPE). The MICT protocol will be increased using a progression schedule previously used (initial intensity at 40% HRR (RPE=9-11), and progressed by 10% HRR every 4 weeks up to 60% HRR (RPE=13-14) will be maintained until the end of the intervention). A 3-minute warm-up and 2-minute cool-down will be performed at 30% HRR (RPE=9-11). The total duration of MICT, including warm-up and cool-down, will be 35 minutes.

    Behavioral: 12 weeks of Moderate-Intensity Continuous Training

Interventions

  • Behavioral12 weeks of High-intensity Interval Training

    Cardiovascular exercise

  • Behavioral12 weeks of Moderate-Intensity Continuous Training

    Cardiovascular exercise

06

What researchers measure

Primary outcomes

  1. Cortico-spinal excitability

    Single pulse of transcranial magnetic stimulation protocol.

    Time frame: 12 weeks

Secondary outcomes

  1. Intra-cortical inhibition

    Paired-pulse of transcranial magnetic stimulation protocol.

    Time frame: 12 weeks

  2. Intra-cortical facilitation

    Paired-pulse of transcranial magnetic stimulation protocol.

    Time frame: 12 weeks

  3. Systolic resting blood pressure

    Supine resting blood pressure.

    Time frame: 12 weeks

  4. Diastolic resting blood pressure

    Supine resting blood pressure.

    Time frame: 12 weeks

  5. Arterial stiffness

    Central pulse wave velocity.

    Time frame: 12 weeks

  6. Cardiorespiratory fitness

    Maximum rate of oxygen consumption measured during maximum physical effort.

    Time frame: 12 weeks

  7. Waist-hip ratio

    Ratio of waist circumference measured at the level of the umbilicus, and hip circumference taken at the level of the greater trochanters.

    Time frame: 12 weeks

Other outcomes

  1. Enjoyment

    The Physical Activity Enjoyment Scale. Each item is scored 1-7 (1=does not make me happy, 7=makes me happy), yielding a total between 8 and 56.

    Time frame: 12 weeks

  2. Motivation

    The Behavioral Regulation Exercise Questionnaire-3. 24 items using a 5-point Likert scale (0=Not true for me, 4=Very true for me).

    Time frame: 12 weeks

  3. Gait speed

    self- and fast-paced 6-meter gait speed.

    Time frame: 12 weeks

  4. Walking capacity

    6-Minute Walk Test.

    Time frame: 12 weeks

  5. Motor learning

    A motor task that requires modulating hand-grasping force. The goal is to apply force, move the cursor, and reach targets displayed on the screen as accurately as possible.

    Time frame: 12 weeks

07

Study locations

2 of 2 sites recruiting
  • Ontario Central South Stroke Network
    Hamilton, Ontario L8L 2X2, Canada
    Recruiting
  • Jewish Rehabiliation Hospital
    Laval, Quebec H7V 1R2, Canada
    Recruiting
    • Marc Roig, PhD · Contactmarc.roigpull@mcgill.ca · 450-688-9550
    • Jean-Francois Nepveu, MSc · Contact450-688-9550
08

References and documents

Publications

  • Rodrigues L, Moncion K, Eng JJ, Noguchi KS, Wiley E, de Las Heras B, Sweet SN, Fung J, MacKay-Lyons M, Nelson AJ, Medeiros D, Crozier J, Thiel A, Tang A, Roig M. Intensity matters: protocol for a randomized controlled trial exercise intervention for individuals with chronic stroke. Trials. 2022 May 24;23(1):442. doi: 10.1186/s13063-022-06359-w. PubMed 35610659 ↗

Individual participant data

Plan to share: No — Results will be publish in peer-review journals.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2020 (actual). Primary completion is estimated for Sep 2024, 56 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 56 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 26, 2018
First posted
Aug 3, 2018
StartActual
Jan 1, 2020
Primary completionEst.
Sep 2024
CompletionEst.
Dec 2024
Last update
Oct 19, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 19, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03614585
Lead sponsor
McGill University
Collaborators
McMaster University, Jewish Rehabilitation Hospital, Ontario Stroke Network, Canadian Institutes of Health Research (CIHR)
Responsible party
Marc Roig (Assistant Professor, McGill University) — Principal investigator
First posted
Aug 3, 2018
Start date
Jan 1, 2020
Primary completion
Sep 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Oct 19, 2023

Study contacts

Marc Roig, PhD
Contact
marc.roigpull@mcgill.ca
514-398-4400 ext. 00841
Ada Tang, PhD
Contact
atang@mcmaster.ca
905-525-9140 ext. 27818
Marc Roig, PhD
principal investigator · McGill University
Ada Tang, PhD
principal investigator · McMaster University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion